Beqalzi Tablet, Film Coated
Product Images NDC 72579-020

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Beqalzi (NDC 72579-020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Beone Medicines Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Beqalzi 01)

Chemical structure of sonrotoclax, the active ingredient in BEQALZI tablets. The diagram shows the molecular framework including rings, bonds, and functional groups characteristic of sonrotoclax.*

FDA Label Image

Principal Display Panel (1 mg Tablet Blister Pack Carton)

Packaging label for BEQALZI (sonrotoclax) tablets, 1 mg per tablet. The label indicates it is an oral film-coated tablet with a count of 11 tablets per package. It includes storage instructions, a warning to keep out of reach of children, and a note to dispense with the enclosed medication guide. The manufacturer is BeOne Medicines USA, Inc.*

FDA Label Image

Principal Display Panel (5 mg Tablet Blister Pack Carton)

Packaging label for BEQALZI (sonrotoclax) tablets, 5 mg per tablet, film-coated oral tablets. The carton displays a warning to swallow tablets whole and not to break, chew, or crush them. The labeler is BeOne Medicines USA, Inc. The package contains 11 tablets and advises dispensing with the enclosed medication guide. Storage instructions and a warning to keep out of reach of children are also present.*

FDA Label Image

Principal Display Panel (20 mg Tablet Blister Pack Carton)

BEQALZI 20 mg tablets packaging label showing sonrotoclax as the active ingredient. The label displays the product name, dosage strength of 20 mg per tablet, and form as film-coated oral tablets. It includes instructions to swallow whole and not break or crush tablets. The package contains 11 tablets and is manufactured for BeOne Medicines USA, Inc.*

FDA Label Image

Principal Display Panel (80 mg Tablet Bottle Carton)

Packaging label for BEQALZI (sonrotoclax) tablets, 80 mg strength. The label indicates oral film-coated tablets, with 120 tablets per package. It includes storage instructions, warnings, manufacturer information for BeOne Medicines USA, Inc., and directions to dispense with the enclosed medication guide. The design features the brand name prominently in orange and blue.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for BEQALZI (sonrotoclax) tablets Starter Pack by BeOne Medicines USA, Inc. The label lists strength options of 1 mg, 5 mg, 20 mg, and 80 mg tablets. It is indicated as a prescription drug and includes instructions to dispense with an enclosed medication guide. The packaging includes manufacturer details and barcodes along with NDC 72579-015-04.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.